We have compiled a countdown of our top 15 content in 2023, here is number 8
By Caitlin McCafferty, Editor
The canine parvovirus monoclonal antibody received conditional license from the US Department of Agriculture. This marks the first approved therapeutic solution to treat canine parvovirus and the first monoclonal antibody for Elanco Animal Health.
Click here to read the full article.